Monday 1 June 2020
Home      All news      Contact us      India
business-standard - 9 days ago

COVID-19 vaccine development at early stage in I breakthrough unlikely within a year: Experts

As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year. The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country. PM CARES Fund Trust has decided to allocate Rs 100 crore for support to coronavirus vaccine development efforts. Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and industry have come together in cutting-edge vaccine design and development. The Department of Biotechnology has been made a central coordination agency to identify pathways for vaccine development. Naming the Indian firms working on vaccines for COVID-19, Gagandeep Kang, executive director of the Translational Health Science and Technology Institute, ...


Latest News
Hashtags:   

COVID

 | 

vaccine

 | 

development

 | 

early

 | 

stage

 | 

breakthrough

 | 

unlikely

 | 

within

 | 

Experts

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources